The VEGFs/VEGFRs system in Alzheimer's and Parkinson's diseases: Pathophysiological roles and therapeutic implications.
作者:
关键词
Alzheimer’s diseaseAngiogenesisAxitinib, PubChem CID: 6450551Cabozantinib, PubChem CID: 25102847Lenvatinib, PubChem CID: 9823820Parkinson’s diseasePazopanib, PubChem CID: 10113978Ponatinib: PubChem CID 24826799Regorafenib, PubChem CID: 11167602Sorafenib, PubChem CID: 216239Sunitinib, PubChem CID: 5329102VEGF-AVEGFR-1VEGFR-2Vandetanib, PubChem CID: 3081361
主题词
动物(Animals);帕金森病(Parkinson Disease);阿尔茨海默病(Alzheimer Disease);血管内皮生长因子受体1(Vascular Endothelial Growth Factor Receptor-1);中枢神经系统(Central Nervous System);脑(Brain)
DOI
10.1016/j.phrs.2024.107101
PMID
38336311
发布时间
2024-03-04
- 浏览0
Pharmacological research
107101页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文